Hytrin and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Hytrin (terazosin hydrochloride), especially for people who are male, 60+ old, also take Coumadin, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Nosebleed when taking Hytrin. It is created by eHealthMe based on reports of 7,298 people who have side effects when taking Hytrin from the FDA, and is updated regularly.

What is Hytrin?

Hytrin has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 7,501 Hytrin users. Check the latest studies of Hytrin.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,073 drugs and 3,094 conditions by eHealthMe. Check the latest studies of Nosebleed.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

7,298 people reported to have side effects when taking Hytrin.
Among them, 61 people (0.84%) have Nosebleed.

Among these 61 people:

What is the gender of people who have Nosebleed when taking Hytrin? *

female: 16.39 %
male: 83.61 %

What is the age of people who have Nosebleed when taking Hytrin? *

What are other drugs people take besides Hytrin? *

What are other side effects people have besides Nosebleed? *

Dyspnea (difficult or laboured breathing): 11 people, 18.03%
Fatigue (feeling of tiredness): 11 people, 18.03%
Fall: 11 people, 18.03%
Nausea (feeling of having an urge to vomit): 10 people, 16.39%
Cough: 9 people, 14.75%
Weight Loss: 9 people, 14.75%
Headache (pain in head): 9 people, 14.75%
Metastases To Bone (cancer spreads to bone): 9 people, 14.75%
Exposed Bone In Jaw: 9 people, 14.75%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 9 people, 14.75%

What are the existing conditions these people have? *

Prostate Cancer Metastatic: 4 people, 6.56%
High Blood Cholesterol: 4 people, 6.56%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 6.56%
Pain: 2 people, 3.28%
Gastric Ulcer (stomach ulcer): 2 people, 3.28%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 3.28%
Chronic Lymphocytic Leukaemia Recurrent (repeated cancer of blood cells known as lymphocytes): 2 people, 3.28%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 3.28%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 3.28%
Acne Cystic (skin problems that cause pimples): 2 people, 3.28%

* Approximation only. Some reports may have incomplete information.

Do you take Hytrin and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hytrin:

Hytrin (7,501 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Hytrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,073 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,094 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on terazosin hydrochloride (the active ingredients of Hytrin) and Hytrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.